The Budget Impact of Brodalumab for the Treatment of Moderate-to-Severe Plaque Psoriasis on U.S. Commercial Health Plans
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1628
https://www.valueinhealthjournal.com/article/S1098-3015(18)31934-X/fulltext
Title :
The Budget Impact of Brodalumab for the Treatment of Moderate-to-Severe Plaque Psoriasis on U.S. Commercial Health Plans
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31934-X&doi=10.1016/j.jval.2018.04.1628
First page :
Section Title :
Open access? :
No
Section Order :
845